Vusumuzi Ngonidzashe Hove, M.S.

Vusumuzi Ngonidzashe Hove is a medicinal chemistry researcher and pharmaceutical scientist specializing in clinical oncology. His research focuses on investigating the therapeutic efficacy, ADME properties, and toxicity of pharmacologic agents (in vitro and in vivo) using pharmacokinetic and pharmacodynamic (PK/PD) modeling approaches. Another area of his work involves identifying clinically relevant drug-drug interactions (DDIs) to guide future regulatory studies on drug disposition. In addition, Hove has explored the use of oxime ligands as Fe(III) MRI contrast agents and as sensors for Fe(III) and Fe(II). Tennis Career Highlights: Vusa Hove competed as a student-athlete at the University at Buffalo for three and a half years on the men’s tennis team rising to the ranking of the number one singles player, a top 125 NCAA Division I singles player, an ITA All-Academic Team selection, UB's all-time leader in combined wins and the tennis programs first Mid-American Conference (MAC) Player of the Year in 2013. He played professional tennis (ATP and ITF) following his undergraduate education. At the completion of his tennis career he received induction into the Buffalo Tennis Hall of Fame in 2019. Educational Background: Hove completed his secondary education at St. George’s College High School in Harare, Zimbabwe, where he sat for the University of Cambridge International O-Level, AS-Level, and A-Level examinations. He then pursued his undergraduate and graduate studies at the University at Buffalo, earning a Bachelor’s degree in Chemistry and two Master of Science degrees in Medicinal Chemistry and Pharmaceutical Sciences. Hove was awarded the Professor Emeritus Dr. Thomas J. Bardos Scholarship, presented by the University at Buffalo School of Pharmacy and Pharmaceutical Sciences.